< Back to Front Page
Text size
–
+
Meeting their Fate
Remember the fanfare when Fate Therapeutics was launched last year?
The startup's goal is to capitalize on the promise of stem cells. To do that it gathered the leading lights of the field, including founders Dr. David Scadden of the Harvard Stem Cell Institute and Massachusetts General Hospital and Dr. Leonard Zon of Harvard University and Children's Hospital Boston. Robert S. Langer Jr. and Ram Sasisekharan of MIT sit on the scientific advisory board.
Find out on xconomy.com how venture capitalists brought them (and other stem-cell stars) together, including a fateful meeting at a French restaurant near Mass. General.
Comment
Permalink
EmailThis blogger might want to review your comment before posting it.
about white coat notes We post updates every weekday about the region's hospitals,
labs and medical schools – covering everything from the latest research findings to
what's on the minds of the innovative doctors, nurses and scientists who work here.
Send news items and tips to whitecoat@globe.com
Contributors
blogger
Elizabeth Cooney is a former
health reporter for the Worcester Telegram & Gazette, where she also was a
business reporter and an editor. Earlier in her career, she edited medical
books and journals at Little, Brown, and worked for Boston magazine.Boston Globe Health and Science staff:
- Gideon Gil, Health and Science Editor
- Ishani Ganguli, Short White Coat blogger
